Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for prevention of bronchiectasis in infants with cystic fibrosis
ACTRN12610001072000Phase 3Active, not recruiting
- Sponsor
- Kids Research Institute Australia
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azithromycin in cystic fibrosis (CF), sponsored by Kids Research Institute Australia. Started Jul 2012; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12610001072000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001072000.